As we found that many NSCLC cell lines co-express EGFR and MET, including H1975 cells, we first investigated if MET inhibition using the small-molecule inhibitor SU11274 can be effective in the erlotinib-resistant H1975 cells. This evidence concerns the gene MET and non-small cell lung carcinoma.